These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11930908)

  • 1. Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration.
    Kong EK; Peng L; Chen Y; Yu AC; Hertz L
    Neurochem Res; 2002 Feb; 27(1-2):113-20. PubMed ID: 11930908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional 'serotonin-specific reuptake inhibitors'.
    Zhang S; Li B; Lovatt D; Xu J; Song D; Goldman SA; Nedergaard M; Hertz L; Peng L
    Neuron Glia Biol; 2010 May; 6(2):113-25. PubMed ID: 20846463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation.
    Li B; Zhang S; Li M; Hertz L; Peng L
    Psychopharmacology (Berl); 2009 Nov; 207(1):1-12. PubMed ID: 19662385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
    Pälvimäki EP; Majasuo H; Syvälahti E; Hietala J
    Pharmacol Res; 2005 May; 51(5):419-25. PubMed ID: 15749456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells.
    Chen Y; Peng L; Zhang X; Stolzenburg JU; Hertz L
    Brain Res Bull; 1995; 38(2):153-9. PubMed ID: 7583341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis.
    He M; Sibille E; Benjamin D; Toth M; Shippenberg T
    Brain Res; 2001 May; 902(1):11-7. PubMed ID: 11376590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.
    Bliziotes MM; Eshleman AJ; Zhang XW; Wiren KM
    Bone; 2001 Nov; 29(5):477-86. PubMed ID: 11704501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac).
    Ni YG; Miledi R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):2036-40. PubMed ID: 9050900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic treatment with fluoxetine on receptor-stimulated increase of [Ca2+]i in astrocytes mimic those of acute inhibition of TRPC1 channel activity.
    Li B; Dong L; Fu H; Wang B; Hertz L; Peng L
    Cell Calcium; 2011 Jul; 50(1):42-53. PubMed ID: 21640379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical spinal 5-HT
    Tadjalli A; Mitchell GS
    J Appl Physiol (1985); 2019 Aug; 127(2):432-443. PubMed ID: 31219768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxytryptamine2B receptors stimulate Ca2+ increases in cultured astrocytes from three different brain regions.
    Sandén N; Thorlin T; Blomstrand F; Persson PA; Hansson E
    Neurochem Int; 2000 Apr; 36(4-5):427-34. PubMed ID: 10733010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytic 5-HT(2B) receptor as in vitro and in vivo target of SSRIs.
    Peng L; Huang J
    Recent Pat CNS Drug Discov; 2012 Dec; 7(3):243-53. PubMed ID: 22963281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
    Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isochromanes related to fluoxetine].
    Unterhalt B; Heppert U
    Pharmazie; 2001 Jun; 56(6):445-7. PubMed ID: 11446162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
    Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine affects GluK2 editing, glutamate-evoked Ca(2+) influx and extracellular signal-regulated kinase phosphorylation in mouse astrocytes.
    Li B; Zhang S; Zhang H; Hertz L; Peng L
    J Psychiatry Neurosci; 2011 Sep; 36(5):322-38. PubMed ID: 21320410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.
    Fabre V; Beaufour C; Evrard A; Rioux A; Hanoun N; Lesch KP; Murphy DL; Lanfumey L; Hamon M; Martres MP
    Eur J Neurosci; 2000 Jul; 12(7):2299-310. PubMed ID: 10947809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus.
    Neumaier JF; Root DC; Hamblin MW
    Neuropsychopharmacology; 1996 Nov; 15(5):515-22. PubMed ID: 8914125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.